SEC Form 4 · accession 0001654954-17-011652
CorMedix Inc. · CRMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mehmood Khan
Director
Period of report
Dec 12, 2017
Accepted (ET)
Dec 14, 2017 · 4:11 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001410098
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 12, 2017 | P | 52,083 | $0.48 | A | 452,083 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy Common Stock)F2 | $0.45 | holding | — | — | — | — | Jun 25, 2027 | Common Stock | 75,000 | 75,000 | D |
Explanation of responses
- F1Purchase was contracted on November 17, 2017, but not closed until December 12, 2017.
- F2These options were granted on 6/25/2017. These options vest 1/3 on the date of grant, 1/3 on the first anniversary of the date of grant and 1/3 on the second anniversary of the date of grant.